Picture of Calcimedica logo

CALC — Calcimedica News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Graybug Vision Inc expected to post a loss of 44 cents a share - Earnings Preview

* Graybug Vision Inc  GRAY.OQ   GRAY.O  is expected to show
no
change in quarterly revenue when it reports  results on November
9 (estimated). 
    * 
    * ​Refinitiv's mean analyst estimate for Graybug Vision Inc
is for
a loss of 44 cents per share. 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Graybug
Vision
Inc is $2.5​, above​ its last closing price of $1.01. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jun. 30 2022  -0.40       -0.40      -0.38     Beat    5.5
 Mar. 31 2022  -0.38       -0.38      -0.48     Missed  -25.5
 Dec. 31 2021  -0.37       -0.37      -0.41     Missed  -12​
 Sep. 30 2021  -0.37       -0.37      -0.38     Missed  -2.7
 ​​Jun.        -0.47       -0.47      -0.36     Beat    23.1
 30 2021                                                
 Mar. 31 2021  -0.44       -0.44      -0.54     Missed  -22.7​
 Dec. 31 2020  -0.40       -0.40      -1.38     Missed  -240.7
 Sep. 30 2020  -0.56       -0.56      -2.52     Missed  -350
 This summary was machine generated November 8 at 03:10 GMT.  All
figures in US dollars  unless otherwise stated

Recent news on Calcimedica

See all news